Switch to:

Biomarin Pharmaceutical Research & Development

: $696 Mil (TTM As of Mar. 2019)
View and export this data going back to 1999. Start your Free Trial

This is the expense the company spent on research and development. Biomarin Pharmaceutical's research and development for the three months ended in Mar. 2019 was $184 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2019 was $696 Mil.


Biomarin Pharmaceutical Research & Development Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data

Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 461.54 634.81 661.91 610.75 696.33

Biomarin Pharmaceutical Quarterly Data

Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.95 175.58 161.41 175.39 183.59

Biomarin Pharmaceutical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2019 was 175.582 (Jun. 2018 ) + 161.408 (Sep. 2018 ) + 175.39 (Dec. 2018 ) + 183.591 (Mar. 2019 ) = $696 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Biomarin Pharmaceutical  (NAS:BMRN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Biomarin Pharmaceutical Research & Development Explanation


Biomarin Pharmaceutical Research & Development Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK